Cytotheryx has developed a bio-incubator for the scalable expansion of a consistent and high-quality source of primary human hepatocytes for use in preclinical toxicology and metabolic safety studies, as well as to enable cell-based therapies for liver disease. Cytotheryx recently launched a primary porcine hepatocyte product for non-human safety and toxicology testing.
Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Appointment Request
Blocked Timeslot
Restricted Timeslot
Copyright © American College of Toxicology. All rights reserved.
You may view the ACT Privacy Policy, Code of Conduct, provide consent to ACT
to email you communications, or unsubscribe to stop receiving further ACT communication.
Privacy Policy | Code of Conduct | Provide Consent | Unsubscribe